Hon Hui from Foster City, CA, age 53

President And Chief Executive Officer

view source

Location:

P/O Box 4004, San Mateo, CA

Industry:

Real Estate

Work:

Synergy Financial Corp Apr 2002 - Jun 2008
Loan Officer
Hkh & Associates Apr 2002 - Jun 2008
President and Chief Executive Officer

Skills:

Real Estate
Commercial Real Estate
Loans
Investment Properties
Residential Homes
Foreclosures
Property Management
Short Sales
Investors
Condos
Reo
Single Family Homes
Real Estate Economics
Real Estate Development
First Time Home Buyers
Finance
Fha

Languages:

Cantonese

Hon Hui

view source

Us Patents

Hydroxamates As Therapeutic Agents
view source
US Patent:

7517988, Apr 14, 2009
Filed:

Nov 14, 2007
Appl. No.:

11/940273
Inventors:

Erik J. Verner - Belmont CA, US
Hon C. Hui - San Mateo CA, US
Assignee:

Pharmacyclics, Inc. - Sunnyvale CA
International Classification:

C07D 215/38
A61K 31/53
US Classification:

546169, 546146, 544235, 544236, 544283, 544349, 514243, 514246, 514249, 5142581, 514299
Abstract:

The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.

Modulators Of Pharmacokinetic Properties Of Therapeutics
view source
US Patent:

8088770, Jan 3, 2012
Filed:

Jul 3, 2008
Appl. No.:

12/217496
Inventors:

Manoj C. Desai - Pleasant Hill CA, US
Hon C. Hui - San Mateo CA, US
Hongtao Liu - Cupertino CA, US
Jianyu Sun - San Mateo CA, US
Lianhong Xu - Palo Alto CA, US
Assignee:

Gilead Sciences, Inc. - Foster City CA
International Classification:

A61K 31/5355
A61K 31/4985
A61K 31/437
A61K 31/4402
A61K 31/426
C07D 417/04
C07D 487/04
C07D 277/24
US Classification:

5142368, 514249, 514303, 514342, 514365, 544133, 544236, 546118, 5462697, 548181, 548204
Abstract:

The present application provides for a compound of Formula IV:.

Modulators Of Toll-Like Receptors
view source
US Patent:

8367670, Feb 5, 2013
Filed:

Dec 7, 2009
Appl. No.:

12/632194
Inventors:

Manoj C. Desai - Pleasant Hill CA, US
Randall L. Halcomb - Foster City CA, US
Paul Hrvatin - South San Francisco CA, US
Hon Chung Hui - San Mateo CA, US
Ryan McFadden - Foster City CA, US
Paul A. Roethle - San Francisco CA, US
Hong Yang - Fremont CA, US
Assignee:

Gilead Sciences, Inc. - Foster City CA
International Classification:

C07D 475/06
C07D 475/08
C07D 475/12
C07D 487/04
A61K 31/519
A61P 31/12
A61P 35/00
US Classification:

514249, 544258, 544259
Abstract:

Provided are modulators of TLRs of Formula II:.

Pyrazolo[1,5-A]Pyrimidines For Antiviral Treatment
view source
US Patent:

8486938, Jul 16, 2013
Filed:

Jun 23, 2011
Appl. No.:

13/167618
Inventors:

Kerim Babaoglu - Pacifica CA, US
Constantine G. Boojamra - San Francisco CA, US
Eugene J. Eisenberg - San Carlos CA, US
Hon Chung Hui - San Mateo CA, US
Richard L. Mackman - Milbrae CA, US
Jay P. Parrish - Redwood City CA, US
Michael Sangi - Oakland CA, US
Oliver L. Saunders - San Mateo CA, US
Dustin Siegel - Foster City CA, US
David Sperandio - Palo Alto CA, US
Hai Yang - San Mateo CA, US
Assignee:

Gilead Sciences, Inc. - Foster City CA
International Classification:

C07D 487/04
A61K 31/519
US Classification:

5142332, 51425931, 544117, 544281
Abstract:

The invention provides compounds of Formula I or Formula II:.

Modulators Of Pharmacokinetic Properties Of Therapeutics
view source
US Patent:

8486942, Jul 16, 2013
Filed:

Nov 21, 2011
Appl. No.:

13/301642
Inventors:

Manoj C. Desai - Pleasant Hill CA, US
Allen Y. Hong - Pasadena CA, US
Hon C. Hui - San Mateo CA, US
Hongtao Liu - Cupertino CA, US
Randall W. Vivian - San Mateo CA, US
Lianhong Xu - Palo Alto CA, US
Assignee:

Gilead Sciencs, Inc. - Foster City CA
International Classification:

A61K 31/5355
US Classification:

5142368
Abstract:

The present application provides for a compound of Formula IV,.

Modulators Of Toll-Like Receptors
view source
US Patent:

8629142, Jan 14, 2014
Filed:

Nov 16, 2012
Appl. No.:

13/679803
Inventors:

Randall L. Halcomb - Foster City CA, US
Paul Hrvatin - South San Francisco CA, US
Hon Chung Hui - San Mateo CA, US
Ryan McFadden - Foster City CA, US
Paul A. Roethle - San Francisco CA, US
Hong Yang - Fremont CA, US
Assignee:

Gilead Sciences, Inc. - Foster City CA
International Classification:

C07D 475/06
C07D 475/08
C07D 475/12
C07D 487/04
A61K 31/519
A61P 31/12
A61P 35/00
US Classification:

514249, 544258, 544259
Abstract:

Provided are modulators of TLRs of Formula II:.

Modulators Of Pharmacokinetic Properties Of Therapeutics
view source
US Patent:

20080207620, Aug 28, 2008
Filed:

Feb 22, 2008
Appl. No.:

12/036124
Inventors:

Manoj C. Desai - Pleasant Hill CA, US
Allen Y. Hong - Pasadena CA, US
Hon C. Hui - San Mateo CA, US
Hongtao Liu - Cupertino CA, US
Randall W. Vivian - San Mateo CA, US
Lianhong Xu - Palo Alto CA, US
International Classification:

A61K 31/5375
C07D 277/22
A61P 31/00
C07D 247/00
A61K 31/44
A61K 31/497
C07D 417/02
A61K 31/426
US Classification:

5142382, 548204, 514365, 544133, 544383, 546209, 51425402, 514326
Abstract:

The present application provides for a compound of Formula IV,or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods and include the administration of such compounds with at least one additional therapeutic agent.

Novel Hydroxamates As Therapeutic Agents
view source
US Patent:

20080255214, Oct 16, 2008
Filed:

Nov 14, 2007
Appl. No.:

11/940260
Inventors:

Erik J. Verner - Belmont CA, US
Hon C. Hui - San Mateo CA, US
Assignee:

PHARMACYCLICS, INC. - Sunnyvale CA
International Classification:

A61K 31/428
C07D 277/68
C07D 263/58
A61K 31/4184
A61P 35/00
C07D 235/24
A61K 31/423
US Classification:

514367, 548180, 548217, 5483094, 514375, 514394
Abstract:

The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.